Xu W - Search Results

1

Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.

Yu J, Ma Q, Zhang B, Ma R, Xu X, Li M, Xu W, Li M. Yu J, et al. Among authors: xu w, xu x. Sci China Life Sci. 2013 Mar;56(3):234-9. doi: 10.1007/s11427-013-4451-y. Epub 2013 Mar 23. Sci China Life Sci. 2013. PMID: 23526389 Free article.

2

Preparation and characterization of monoclonal antibody against glypican-3.

Ma RJ, Wang SH, Qin SN, Wang XB, Li GF, Li M, Xu WW. Ma RJ, et al. Hybridoma (Larchmt). 2012 Dec;31(6):455-61. doi: 10.1089/hyb.2012.0030. Hybridoma (Larchmt). 2012. PMID: 23244326

3

Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma.

Yu JP, Xu XG, Ma RJ, Qin SN, Wang CR, Wang XB, Li M, Li MS, Ma Q, Xu WW. Yu JP, et al. J Clin Lab Anal. 2015 Mar;29(2):85-93. doi: 10.1002/jcla.21733. Epub 2014 Mar 28. J Clin Lab Anal. 2015. PMID: 24687454 Free PMC article.

4

A monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2.

Du H, Jie L, Xu W, Wu Y, Liu T, Li M. Du H, et al. Among authors: xu w. Hybridoma (Larchmt). 2012 Jun;31(3):196-202. doi: 10.1089/hyb.2012.0005. Hybridoma (Larchmt). 2012. PMID: 22741584 Free PMC article.

5

Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Sun JZ, Yang XX, Li XH, Xu WW, Wang Y, Zhu W, Li M. Sun JZ, et al. Among authors: xu ww. Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30. Dig Dis Sci. 2011. PMID: 21448695

6

The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer.

Zhang Q, Wang CR, Yu JP, Ma Q, Xu WW. Zhang Q, et al. J Clin Lab Anal. 2016 Sep;30(5):709-18. doi: 10.1002/jcla.21926. Epub 2016 Mar 17. J Clin Lab Anal. 2016. PMID: 26990679 Free PMC article.

7

Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.

Chen JJ, Xie CM, Wang CR, Wan Y, Dong ZN, Li M, Xu WW. Chen JJ, et al. J Fluoresc. 2017 Jul;27(4):1479-1485. doi: 10.1007/s10895-017-2087-1. Epub 2017 Apr 20. J Fluoresc. 2017. PMID: 28429175

8

RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.

Wang S, Huang X, Li Y, Lao H, Zhang Y, Dong H, Xu W, Li JL, Li M. Wang S, et al. Among authors: xu w. Hepatology. 2011 Jun;53(6):1932-42. doi: 10.1002/hep.24291. Epub 2011 May 2. Hepatology. 2011. PMID: 21391225

9

Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.

Wang C, Shao X, Zhang X, Xie C, Yu J, Xu X, Yang J, Li Y, Xu W. Wang C, et al. Among authors: xu w, xu x. Transl Cancer Res. 2020 Jan;9(1):128-136. doi: 10.21037/tcr.2019.11.20. Transl Cancer Res. 2020. PMID: 35117166 Free PMC article.

10

[Preparation of time-resolved fluoroimmunoassay kit for human alpha-fetoprotein detection].

Hang JF, Wu YS, Yu WH, Xu WW, Wang CR, Qiu YR, Li M. Hang JF, et al. Di Yi Jun Yi Da Xue Xue Bao. 2005 Mar;25(3):313-7. Di Yi Jun Yi Da Xue Xue Bao. 2005. PMID: 15772001 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,216 results

Search Page

Filters